443 related articles for article (PubMed ID: 32090326)
1. Biological concepts in human sodium channel epilepsies and their relevance in clinical practice.
Brunklaus A; Du J; Steckler F; Ghanty II; Johannesen KM; Fenger CD; Schorge S; Baez-Nieto D; Wang HR; Allen A; Pan JQ; Lerche H; Heyne H; Symonds JD; Zuberi SM; Sanders S; Sheidley BR; Craiu D; Olson HE; Weckhuysen S; DeJonge P; Helbig I; Van Esch H; Busa T; Milh M; Isidor B; Depienne C; Poduri A; Campbell AJ; Dimidschstein J; Møller RS; Lal D
Epilepsia; 2020 Mar; 61(3):387-399. PubMed ID: 32090326
[TBL] [Abstract][Full Text] [Related]
2. Comparison and optimization of in silico algorithms for predicting the pathogenicity of sodium channel variants in epilepsy.
Holland KD; Bouley TM; Horn PS
Epilepsia; 2017 Jul; 58(7):1190-1198. PubMed ID: 28518218
[TBL] [Abstract][Full Text] [Related]
3. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications.
Johannesen KM; Liu Y; Koko M; Gjerulfsen CE; Sonnenberg L; Schubert J; Fenger CD; Eltokhi A; Rannap M; Koch NA; Lauxmann S; Krüger J; Kegele J; Canafoglia L; Franceschetti S; Mayer T; Rebstock J; Zacher P; Ruf S; Alber M; Sterbova K; Lassuthová P; Vlckova M; Lemke JR; Platzer K; Krey I; Heine C; Wieczorek D; Kroell-Seger J; Lund C; Klein KM; Au PYB; Rho JM; Ho AW; Masnada S; Veggiotti P; Giordano L; Accorsi P; Hoei-Hansen CE; Striano P; Zara F; Verhelst H; Verhoeven JS; Braakman HMH; van der Zwaag B; Harder AVE; Brilstra E; Pendziwiat M; Lebon S; Vaccarezza M; Le NM; Christensen J; Grønborg S; Scherer SW; Howe J; Fazeli W; Howell KB; Leventer R; Stutterd C; Walsh S; Gerard M; Gerard B; Matricardi S; Bonardi CM; Sartori S; Berger A; Hoffman-Zacharska D; Mastrangelo M; Darra F; Vøllo A; Motazacker MM; Lakeman P; Nizon M; Betzler C; Altuzarra C; Caume R; Roubertie A; Gélisse P; Marini C; Guerrini R; Bilan F; Tibussek D; Koch-Hogrebe M; Perry MS; Ichikawa S; Dadali E; Sharkov A; Mishina I; Abramov M; Kanivets I; Korostelev S; Kutsev S; Wain KE; Eisenhauer N; Wagner M; Savatt JM; Müller-Schlüter K; Bassan H; Borovikov A; Nassogne MC; Destrée A; Schoonjans AS; Meuwissen M; Buzatu M; Jansen A; Scalais E; Srivastava S; Tan WH; Olson HE; Loddenkemper T; Poduri A; Helbig KL; Helbig I; Fitzgerald MP; Goldberg EM; Roser T; Borggraefe I; Brünger T; May P; Lal D; Lederer D; Rubboli G; Heyne HO; Lesca G; Hedrich UBS; Benda J; Gardella E; Lerche H; Møller RS
Brain; 2022 Sep; 145(9):2991-3009. PubMed ID: 34431999
[TBL] [Abstract][Full Text] [Related]
4. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome?
Lim BC; Hwang H; Kim H; Chae JH; Choi J; Kim KJ; Hwang YS; Yum MS; Ko TS
Epilepsy Res; 2015 Jan; 109():34-9. PubMed ID: 25524840
[TBL] [Abstract][Full Text] [Related]
5. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.
Wolff M; Johannesen KM; Hedrich UBS; Masnada S; Rubboli G; Gardella E; Lesca G; Ville D; Milh M; Villard L; Afenjar A; Chantot-Bastaraud S; Mignot C; Lardennois C; Nava C; Schwarz N; Gérard M; Perrin L; Doummar D; Auvin S; Miranda MJ; Hempel M; Brilstra E; Knoers N; Verbeek N; van Kempen M; Braun KP; Mancini G; Biskup S; Hörtnagel K; Döcker M; Bast T; Loddenkemper T; Wong-Kisiel L; Baumeister FM; Fazeli W; Striano P; Dilena R; Fontana E; Zara F; Kurlemann G; Klepper J; Thoene JG; Arndt DH; Deconinck N; Schmitt-Mechelke T; Maier O; Muhle H; Wical B; Finetti C; Brückner R; Pietz J; Golla G; Jillella D; Linnet KM; Charles P; Moog U; Õiglane-Shlik E; Mantovani JF; Park K; Deprez M; Lederer D; Mary S; Scalais E; Selim L; Van Coster R; Lagae L; Nikanorova M; Hjalgrim H; Korenke GC; Trivisano M; Specchio N; Ceulemans B; Dorn T; Helbig KL; Hardies K; Stamberger H; de Jonghe P; Weckhuysen S; Lemke JR; Krägeloh-Mann I; Helbig I; Kluger G; Lerche H; Møller RS
Brain; 2017 May; 140(5):1316-1336. PubMed ID: 28379373
[TBL] [Abstract][Full Text] [Related]
6. SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis.
Haerian BS; Baum L; Kwan P; Tan HJ; Raymond AA; Mohamed Z
Pharmacogenomics; 2013 Jul; 14(10):1153-66. PubMed ID: 23859570
[TBL] [Abstract][Full Text] [Related]
7. Heterozygous deletion of SCN2A and SCN3A in a patient with autism spectrum disorder and Tourette syndrome: a case report.
Nickel K; Tebartz van Elst L; Domschke K; Gläser B; Stock F; Endres D; Maier S; Riedel A
BMC Psychiatry; 2018 Aug; 18(1):248. PubMed ID: 30071822
[TBL] [Abstract][Full Text] [Related]
8. Association of sodium voltage-gated channel genes polymorphisms with epilepsy risk and prognosis in the Saudi population.
Alghamdi MA; Al-Eitan LN; Asiri A; Rababa'h DM; Alqahtani SA; Aldarami MS; Alsaeedi MA; Almuidh RS; Alzahrani AA; Sakah AH; El Nashar EM; Otaif MY; Abdel Ghaffar NF
Ann Med; 2022 Dec; 54(1):1938-1951. PubMed ID: 35801810
[TBL] [Abstract][Full Text] [Related]
9. Neuronal voltage-gated ion channels are genetic modifiers of generalized epilepsy with febrile seizures plus.
Hawkins NA; Martin MS; Frankel WN; Kearney JA; Escayg A
Neurobiol Dis; 2011 Mar; 41(3):655-60. PubMed ID: 21156207
[TBL] [Abstract][Full Text] [Related]
10. The phenotype and treatment of SCN2A-related developmental and epileptic encephalopathy.
Kim HJ; Yang D; Kim SH; Kim B; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC
Epileptic Disord; 2020 Oct; 22(5):563-570. PubMed ID: 33000761
[TBL] [Abstract][Full Text] [Related]
11. High-throughput electrophysiological assays for voltage gated ion channels using SyncroPatch 768PE.
Li T; Lu G; Chiang EY; Chernov-Rogan T; Grogan JL; Chen J
PLoS One; 2017; 12(7):e0180154. PubMed ID: 28683073
[TBL] [Abstract][Full Text] [Related]
12. Interstitial 2q24.3 deletion including SCN2A and SCN3A genes in a patient with autistic features, psychomotor delay, microcephaly and no history of seizures.
Celle ME; Cuoco C; Porta S; Gimelli G; Tassano E
Gene; 2013 Dec; 532(2):294-6. PubMed ID: 24080482
[TBL] [Abstract][Full Text] [Related]
13. Association between SCN1A and SCN2A mutations and clinical/EEG features in Chinese patients from epilepsy or severe seizures.
Kong Y; Yan K; Hu L; Wang M; Dong X; Lu Y; Wu B; Wang H; Yang L; Zhou W
Clin Chim Acta; 2018 Aug; 483():14-19. PubMed ID: 29649454
[TBL] [Abstract][Full Text] [Related]
14. Whole gene duplication of SCN2A and SCN3A is associated with neonatal seizures and a normal intellectual development.
Thuresson AC; Van Buggenhout G; Sheth F; Kamate M; Andrieux J; Clayton Smith J; Soussi Zander C
Clin Genet; 2017 Jan; 91(1):106-110. PubMed ID: 27153334
[TBL] [Abstract][Full Text] [Related]
15. Sodium channelopathies in neurodevelopmental disorders.
Meisler MH; Hill SF; Yu W
Nat Rev Neurosci; 2021 Mar; 22(3):152-166. PubMed ID: 33531663
[TBL] [Abstract][Full Text] [Related]
16. The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications.
Brunklaus A; Brünger T; Feng T; Fons C; Lehikoinen A; Panagiotakaki E; Vintan MA; Symonds J; Andrew J; Arzimanoglou A; Delima S; Gallois J; Hanrahan D; Lesca G; MacLeod S; Marjanovic D; McTague A; Nuñez-Enamorado N; Perez-Palma E; Scott Perry M; Pysden K; Russ-Hall SJ; Scheffer IE; Sully K; Syrbe S; Vaher U; Velayutham M; Vogt J; Weiss S; Wirrell E; Zuberi SM; Lal D; Møller RS; Mantegazza M; Cestèle S
Brain; 2022 Nov; 145(11):3816-3831. PubMed ID: 35696452
[TBL] [Abstract][Full Text] [Related]
17.
Yang XR; Ginjupalli VKM; Theriault O; Poulin H; Appendino JP; Au PYB; Chahine M
J Neurophysiol; 2022 May; 127(5):1388-1397. PubMed ID: 35417276
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the sodium channel genes SCN1A, SCN3A, and SCN9A in children with epilepsy with febrile seizures plus(EFS+).
Ma H; Guo Y; Chen Z; Wang L; Tang Z; Zhang J; Miao Q; Zhai Q
Seizure; 2021 May; 88():146-152. PubMed ID: 33895391
[TBL] [Abstract][Full Text] [Related]
19. Commonalities and distinctions between two neurodevelopmental disorder subtypes associated with SCN2A and SCN8A variants and literature review.
Mangano GD; Fontana A; Antona V; Salpietro V; Mangano GR; Giuffrè M; Nardello R
Mol Genet Genomic Med; 2022 May; 10(5):e1911. PubMed ID: 35348308
[TBL] [Abstract][Full Text] [Related]
20. Modulating effects of FGF12 variants on Na
Seiffert S; Pendziwiat M; Bierhals T; Goel H; Schwarz N; van der Ven A; Boßelmann CM; Lemke J; Syrbe S; Willemsen MH; Hedrich UBS; Helbig I; Weber Y
EBioMedicine; 2022 Sep; 83():104234. PubMed ID: 36029553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
